Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,488,000 | 5,840,000 | 6,166,000 | 6,329,000 | 7,832,000 |
| Marketable Securities | 37,000 | 20,000 | 77,000 | 69,000 | 160,000 |
| Inventories | 5,288,000 | 5,424,000 | 4,699,000 | 8,983,000 | 4,024,000 |
| Other current assets | 13,277,000 | 12,153,000 | 10,322,000 | 9,351,000 | 5,793,000 |
| TOTAL | $25,827,000 | $25,054,000 | $22,593,000 | $26,244,000 | $19,544,000 |
| Non-Current Assets | |||||
| PPE Net | 11,647,000 | 10,502,000 | 9,449,000 | 10,171,000 | 8,917,000 |
| Intangibles | 58,202,000 | 58,137,000 | 59,127,000 | 62,384,000 | 32,792,000 |
| Other Non-Current Assets | 8,359,000 | 7,426,000 | 5,314,000 | 6,564,000 | 5,476,000 |
| TOTAL | $78,208,000 | $76,065,000 | $73,890,000 | $79,119,000 | $47,185,000 |
| Total Assets | $104,035,000 | $101,119,000 | $96,483,000 | $105,363,000 | $66,729,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,156,000 | 5,129,000 | 5,314,000 | 1,660,000 | 2,194,000 |
| Accounts payable and accrued liabilities | 3,640,000 | 3,267,000 | 2,550,000 | 2,824,000 | 2,350,000 |
| TOTAL | $27,866,000 | $30,542,000 | $26,293,000 | $22,594,000 | $20,307,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,506,000 | 22,365,000 | 22,965,000 | 28,134,000 | 17,505,000 |
| Other Non-Current Liabilities | 4,289,000 | 5,315,000 | 6,463,000 | 8,343,000 | 9,818,000 |
| TOTAL | $35,298,000 | $31,411,000 | $33,132,000 | $43,482,000 | $30,784,000 |
| Total Liabilities | $63,164,000 | $61,953,000 | $59,425,000 | $66,076,000 | $51,091,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 388,000 | 387,000 | 387,000 | 328,000 |
| Retained earnings | 3,160,000 | 1,502,000 | -574,000 | 1,710,000 | 5,299,000 |
| Other shareholders' equity | 1,859,000 | 1,912,000 | 1,916,000 | 1,892,000 | 1,871,000 |
| TOTAL | $40,786,000 | $39,143,000 | $37,037,000 | $39,268,000 | $15,622,000 |
| Total Liabilities And Equity | $103,950,000 | $101,096,000 | $96,462,000 | $105,344,000 | $66,713,000 |